{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:55:41Z","timestamp":1761252941212},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2369-15-182","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T20:02:31Z","timestamp":1416513751000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study"],"prefix":"10.1186","volume":"15","author":[{"given":"Andrew P","family":"McGovern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"van Vlymen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand K","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"874_CR1","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","volume":"13","author":"P Igarashi","year":"2002","unstructured":"Igarashi P, Somlo S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002, 13: 2384-2398. 10.1097\/01.ASN.0000028643.17901.42.","journal-title":"J Am Soc Nephrol"},{"key":"874_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMra022161","volume":"350","author":"PD Wilson","year":"2004","unstructured":"Wilson PD: Polycystic kidney disease. N Engl J Med. 2004, 350: 151-164. 10.1056\/NEJMra022161.","journal-title":"N Engl J Med"},{"key":"874_CR3","first-page":"1","volume":"328","author":"OZ Dalgaard","year":"1957","unstructured":"Dalgaard OZ: Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957, 328: 1-255.","journal-title":"Acta Med Scand Suppl"},{"key":"874_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","volume":"2","author":"CG Iglesias","year":"1983","unstructured":"Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980. Am J Kidney Dis. 1983, 2: 630-639. 10.1016\/S0272-6386(83)80044-4.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"874_CR5","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/ndt\/gfu087","volume":"29","author":"C Shaw","year":"2014","unstructured":"Shaw C, Simms RJ, Pitcher D, Sandford R: Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure. Nephrol Dial Transplant. 2014, 29 (10): 1910-1918. 10.1093\/ndt\/gfu087.","journal-title":"Nephrol Dial Transplant"},{"key":"874_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Ferec C, Le Meur Y: Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013, 24: 1006-1013. 10.1681\/ASN.2012070650.","journal-title":"J Am Soc Nephrol"},{"key":"874_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman AB, Johnson A, Gabow PA, Schrier RW: The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med. 1990, 323: 1091-1096. 10.1056\/NEJM199010183231602.","journal-title":"N Engl J Med"},{"key":"874_CR8","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ki.1988.115","volume":"33","author":"PC Graham","year":"1988","unstructured":"Graham PC, Lindop GB: The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int. 1988, 33: 1084-1090. 10.1038\/ki.1988.115.","journal-title":"Kidney Int"},{"key":"874_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone RD, Ruthazer R, Terrin NC: Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001, 38: 777-784. 10.1053\/ajkd.2001.27720.","journal-title":"Am J Kidney Dis"},{"key":"874_CR10","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992, 41: 1311-1319. 10.1038\/ki.1992.195.","journal-title":"Kidney Int"},{"key":"874_CR11","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","volume":"59","author":"GM Fick-Brosnahan","year":"2001","unstructured":"Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA: Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 2001, 59: 1654-1662. 10.1046\/j.1523-1755.2001.0590051654.x.","journal-title":"Kidney Int"},{"key":"874_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000046231","volume":"21","author":"T Ecder","year":"2001","unstructured":"Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW: Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol. 2001, 21: 98-103. 10.1159\/000046231.","journal-title":"Am J Nephrol"},{"key":"874_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1523-1755.2003.00776.x","volume":"63","author":"RW Schrier","year":"2003","unstructured":"Schrier RW, McFann KK, Johnson AM: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int. 2003, 63: 678-685. 10.1046\/j.1523-1755.2003.00776.x.","journal-title":"Kidney Int"},{"key":"874_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2215\/CJN.04310709","volume":"5","author":"AB Chapman","year":"2010","unstructured":"Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Kelleher C, Schrier RW: The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol. 2010, 5: 102-109. 10.2215\/CJN.04310709.","journal-title":"Clin J Am Soc Nephrol"},{"key":"874_CR15","volume-title":"Kidney Int","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW: Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int. 2014, 2014: \n                    http:\/\/www.nature.com\/ki\/journal\/vaop\/ncurrent\/full\/ki2014120a.html\n                    \n                  ,"},{"key":"874_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/nep.12211","volume":"19","author":"TM Myint","year":"2014","unstructured":"Myint TM, Rangan GK, Webster AC: Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta-analysis of randomized trials. Nephrology. 2014, 19: 217-226. 10.1111\/nep.12211.","journal-title":"Nephrology"},{"key":"874_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, Epstein FH: Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 2005, 68: 206-216. 10.1111\/j.1523-1755.2005.00395.x.","journal-title":"Kidney Int"},{"key":"874_CR18","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, Visciano B, Imbriaco M, Messa P, Cerutti R, Dugo M, Cancian L, Buongiorno E, De Pascalis A, Gaspari F, Carrara F, Rubis N, Prandini S, Remuzzi A, Remuzzi G, Ruggenenti P: Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet. 2013, 382: 1485-1495. 10.1016\/S0140-6736(13)61407-5.","journal-title":"Lancet"},{"key":"874_CR19","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1681\/ASN.2009121291","volume":"21","author":"MC Hogan","year":"2010","unstructured":"Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE: Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol. 2010, 21: 1052-1061. 10.1681\/ASN.2009121291.","journal-title":"J Am Soc Nephrol"},{"key":"874_CR20","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012, 367: 2407-2418. 10.1056\/NEJMoa1205511.","journal-title":"N Engl J Med"},{"key":"874_CR21","volume-title":"Medscape Medical News","author":"T Brown","year":"2013","unstructured":"Brown T: Tolvaptan Not Recommended for ADPKD. Medscape Medical News. 2013, New York, USA: Medscape"},{"key":"874_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/aps.2011.29","volume":"32","author":"Y Sun","year":"2011","unstructured":"Sun Y, Zhou H, Yang BX: Drug discovery for polycystic kidney disease. Acta Pharmacol Sin. 2011, 32: 805-816. 10.1038\/aps.2011.29.","journal-title":"Acta Pharmacol Sin"},{"key":"874_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ki.2013.96","volume":"84","author":"S de Lusignan","year":"2013","unstructured":"de Lusignan S, Gallagher H, Jones S, Chan T, van Vlymen J, Tahir A, Thomas N, Jain N, Dmitrieva O, Rafi I, McGovern A, Harris K: Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results. Kidney Int. 2013, 84: 609-620. 10.1038\/ki.2013.96.","journal-title":"Kidney Int"},{"key":"874_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01.JAC.0000324664.88131.d2","volume":"31","author":"S de Lusignan","year":"2008","unstructured":"de Lusignan S, Chan T: The development of primary care information technology in the United kingdom. J Ambul Care Manage. 2008, 31: 201-210. 10.1097\/01.JAC.0000324664.88131.d2.","journal-title":"J Ambul Care Manage"},{"key":"874_CR25","doi-asserted-by":"publisher","first-page":"c213","DOI":"10.1159\/000320341","volume":"117","author":"S de Lusignan","year":"2011","unstructured":"de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H: Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clin Pract. 2011, 117: c213-c224. 10.1159\/000320341.","journal-title":"Nephron Clin Pract"},{"key":"874_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139: 137-147. 10.7326\/0003-4819-139-2-200307150-00013.","journal-title":"Ann Intern Med"},{"key":"874_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/1471-2369-14-198","volume":"14","author":"AP McGovern","year":"2013","unstructured":"McGovern AP, Rusholme B, Jones S, van Vlymen JN, Liyanage H, Gallagher H, Tomson CR, Khunti K, Harris K, de Lusignan S: Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study. BMC Nephrol. 2013, 14: 198-10.1186\/1471-2369-14-198.","journal-title":"BMC Nephrol"},{"key":"874_CR28","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","volume":"28","author":"HP Neumann","year":"2013","unstructured":"Neumann HP, Jilg C, Bacher J, Nabulsi Z, Malinoc A, Hummel B, Hoffmann MM, Ortiz-Bruechle N, Glasker S, Pisarski P, Neeff H, Kramer-Guth A, Cybulla M, Hornberger M, Wilpert J, Funk L, Baumert J, Paatz D, Baumann D, Lahl M, Felten H, Hausberg M, Zerres K, Eng C: Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant. 2013, 28: 1472-1487. 10.1093\/ndt\/gfs551.","journal-title":"Nephrol Dial Transplant"},{"key":"874_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/fampra\/cmi106","volume":"23","author":"S de Lusignan","year":"2006","unstructured":"de Lusignan S, van Weel C: The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract. 2006, 23: 253-263.","journal-title":"Fam Pract"},{"key":"874_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1464-5491.2011.03419.x","volume":"29","author":"S de Lusignan","year":"2012","unstructured":"de Lusignan S, Sadek N, Mulnier H, Tahir A, Russell-Jones D, Khunti K: Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabet Med. 2012, 29: 181-189. 10.1111\/j.1464-5491.2011.03419.x.","journal-title":"Diabet Med"},{"key":"874_CR31","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2215\/CJN.02190606","volume":"1","author":"Y Pei","year":"2006","unstructured":"Pei Y: Diagnostic approach in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2006, 1: 1108-1114. 10.2215\/CJN.02190606.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-15-182\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:25:44Z","timestamp":1548195944000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-15-182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-15-182","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]},"assertion":[{"value":"13 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"182"}}